In a large-scale analysis, researchers determined whether endovascular mechanical thrombectomy is a safe and effective therapy for acute ischemic stroke during pregnancy and the postpartum period.
Researchers in China developed a wearable Doppler device to test whether it could provide a noninvasive accurate measurement of blood flow velocity in human arteries and enhance quality of care following reconstruction surgery.
An AAO 2021 presentation reviewed clinical trial data of intravitreal pegcetacoplan, a targeted C3 inhibitor, in controlling lesion growth in patients with geographic atrophy.
A team of investigators conducted a cross-sectional study to explore the association between an increased pain threshold and risk of self-harm in youth.
The researchers sought to determine the clinical and biochemical features of alemtuzumab-induced autoimmune thyroid events and look their risk factors with a focus on fluctuating Graves’ disease.
Presenting at AAO 2021, researchers examined the efficacy of intravenous infusions of teprotumumab, an IGF-IR inhibitor, in patients with thyroid eye disease with low inflammation.
Researchers sought to determine whether patients with Parkinson disease eligible to subthalamic deep brain stimulation with probable REM sleep behavior disorder preoperatively could be more at risk of poor outcomes 12 months after surgery.
Endovascular treatment alone is neither superior nor noninferior to intravenous alteplase followed by EVT in a cohort of European patients with stroke.
